http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6238877-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c1046ab0ae7c1aed16d5d0c0f8fd496 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 1998-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a167e27b0f44a4a109f0609e7279afd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_724f5f107ef740c491246770f7aac923 |
| publicationDate | 2001-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6238877-B1 |
| titleOfInvention | Method for prediction prostate cancer patients' resistance to hormonal treatment by measuring serum concentrations of chromogranin A |
| abstract | The present invention relates to a method for early prediction of a prostate cancer patient's response to hormonal treatment. In one embodiment, the method of the present invention involves assaying a body fluid, such as plasma or serum, from a prostate cancer patient for the presence of elevated levels of chromogranin A (CgA). Elevated levels of CgA may indicate neuroendocrine differentiation of cells within the prostate tumor, and may require altering the patient's treatment. In a further embodiment of the method of the present invention, periodic assays for CgA are conducted for a patient undergoing hormonal treatment for prostate cancer. The results of these assays are correlated to determine if the patient's levels of CgA are high (greater than 100 ng/mL) or increasing. Such assays may also be carried out in conjunction with assays for total prostate specific antigen (tPSA). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010147274-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497074-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011223106-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10648984-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11719697-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3633378-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7713693-B1 |
| priorityDate | 1997-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 192.